We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $22.2B
1-Year Est. Return 58.34%
This Fund
S&P 500
This Quarter Est. Return
+31.13%
1 Year Est. Return
+58.34%
3 Year Est. Return
+153.02%
5 Year Est. Return
+199.78%
10 Year Est. Return
+811.75%
AUM
$22.2B
AUM Growth
+$2.96B
Cap. Flow
-$534M
Cap. Flow %
-2.4%
Top 10 Hldgs %
32.73%
Holding
727
New
37
Increased
291
Reduced
287
Closed
50

Top Buys

Rank Stock Value
1
AVGO icon
Broadcom
AVGO
+$110M
2
ENTG icon
Entegris
ENTG
+$53.1M
3
HLT icon
Hilton Worldwide
HLT
+$45.7M
4
ISRG icon
Intuitive Surgical
ISRG
+$44.3M
5
WDC icon
Western Digital
WDC
+$41.5M

Top Sells

Rank Stock Value
1
MU icon
Micron Technology
MU
+$68.2M
2
JNJ icon
Johnson & Johnson
JNJ
+$67.3M
3
MSFT icon
Microsoft
MSFT
+$64.1M
4
GILD icon
Gilead Sciences
GILD
+$63.1M
5
ON icon
ON Semiconductor
ON
+$62.5M

Sector Composition

Rank Sector Weight
1 Technology 38.31%
2 Healthcare 24.36%
3 Financials 9.42%
4 Communication Services 7.08%
5 Consumer Discretionary 6.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MBX
226
MBX Biosciences
MBX
$2.97B
$16M 0.07%
289,893
-4,481
-2% -$157K
WMG icon
227
Warner Music
WMG
$15.1B
$16M 0.07%
590,553
+46,033
+8% +$1.37M
QCOM icon
228
Qualcomm
QCOM
$180B
$15.8M 0.07%
85,542
-4,922
-5% -$920K
GLW icon
229
Corning
GLW
$133B
$15.8M 0.07%
61,781
-5,010
-8% -$912K
SMTC icon
230
Semtech
SMTC
$13.8B
$15.7M 0.07%
97,140
STOK icon
231
Stoke Therapeutics
STOK
$1.92B
$15.7M 0.07%
480,136
-21,884
-4% -$702K
VLO icon
232
Valero Energy
VLO
$107B
$15.7M 0.07%
60,273
-40,821
-40% -$10.1M
SBUX icon
233
Starbucks
SBUX
$119B
$15.7M 0.07%
153,492
+5,995
+4% +$604K
BSX icon
234
Boston Scientific
BSX
$69.3B
$15.7M 0.07%
367,485
-893,976
-71% -$48.5M
IEX icon
235
IDEX
IEX
$16.5B
$15.6M 0.07%
68,975
+3,344
+5% +$707K
APH icon
236
Amphenol
APH
$204B
$15M 0.07%
170,418
+2,152
+1% +$155K
MLTX icon
237
MoonLake Immunotherapeutics
MLTX
$1.28B
$15M 0.07%
769,766
-48,360
-6% -$877K
LEGN icon
238
Legend Biotech
LEGN
$4.19B
$14.6M 0.07%
504,924
+34,632
+7% +$934K
RAPP
239
Rapport Therapeutics
RAPP
$2.2B
$14.5M 0.07%
347,650
+161,725
+87% +$5.94M
IMNM icon
240
Immunome
IMNM
$3.04B
$14.4M 0.06%
680,132
+140,250
+26% +$3M
FERG icon
241
Ferguson
FERG
$44.2B
$14.4M 0.06%
60,612
-523
-0.9% -$126K
BLK icon
242
Blackrock
BLK
$174B
$14.3M 0.06%
14,897
+17
+0.1% +$17.6K
NET icon
243
Cloudflare
NET
$99.3B
$14.3M 0.06%
58,366
-2,445
-4% -$535K
IR icon
244
Ingersoll Rand
IR
$29.6B
$14.2M 0.06%
172,809
+1,489
+0.9% +$115K
PAM icon
245
Pampa Energía
PAM
$4.55B
$13.9M 0.06%
+170,000
New +$14.2M
KIM icon
246
Kimco Realty
KIM
$15.8B
$13.7M 0.06%
541,423
+463,442
+594% +$11.1M
MEDP icon
247
Medpace
MEDP
$16.5B
$13.7M 0.06%
25,876
-77,473
-75% -$35.8M
MDLZ icon
248
Mondelez International
MDLZ
$78.2B
$13.6M 0.06%
236,094
+5,358
+2% +$323K
HAS icon
249
Hasbro
HAS
$13.1B
$13.6M 0.06%
164,273
+88,664
+117% +$7.98M
GH icon
250
Guardant Health
GH
$21.7B
$13.5M 0.06%
90,197
+981
+1% +$107K

Similar funds

Candriam SCA's Q2 2026 Portfolio in Review

As of Q2 2026, Candriam SCA held 727 positions worth $22.2B, up 15% from $19.3B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Candriam SCA's Q2 2026 filing shows 37 new, 291 increased, 287 reduced and 50 closed positions. Its largest new stake was BBVA Argentina: 1,335,000 shares worth $26.2M. The largest sale was Micron Technology, an estimated $68.2M.

By sector, the portfolio is most concentrated in Technology at 38% of assets, up from 33% a quarter earlier, followed by Healthcare and Financials.

  • Candriam SCA's largest Q2 2026 buy was BBVA Argentina: 1,335,000 shares worth $26.2M.
  • Candriam SCA added most to Broadcom in Q2 2026, an estimated $110M increase.
  • Candriam SCA's biggest Q2 2026 reduction was Micron Technology, cutting an estimated $68.2M.
  • Candriam SCA fully exited Ascendis Pharma A/S in Q2 2026, selling an estimated $52.7M.
  • Candriam SCA's ten largest holdings make up 33% of its $22.2B portfolio in Q2 2026.
  • Candriam SCA opened 37 new positions and closed 50 in Q2 2026.
  • Candriam SCA's portfolio value rose 15% quarter-over-quarter to $22.2B.

Based on Candriam SCA's 13F filing for Q2 2026, filed 13 Aug 2026.